INTRODUCTION
Partial hepatectomy or dissociation followed by primary culturing triggers the entry of hepatocytes into the cell cycle [1] [2] [3] . Maximal DNA synthesis in i o occurs between 12 and 36 h after two-thirds partial hepatectomy. Primary culturing in itro in the presence of growth factors such as insulin, epidermal growth factor or hepatocyte growth factor stimulates hepatocyte DNA synthesis, which is maximal between 40 and 70 h after isolation [3] [4] [5] [6] . Hepatocytes do not terminally differentiate and can enter and exit the cell cycle during cycles of liver regeneration. This is in contrast with other cell types, such as intestinal epithelial cells and keratinocytes, which undergo irreversible terminal differentiation [7, 8] .
Abbreviations used : cdk, cyclin-dependent kinase ; C/EBP, CCAATT enhancer-binding protein ; CKI, cyclin-dependent kinase inhibitor ; DMEM, Dulbecco's modified Eagle's medium ; ∆Raf : ER, oestrogen receptor-Raf-1 fusion protein, ∆Raf : ER(301), oestrogen receptor-Raf-1 (kinase-inactive) fusion protein ; GST, glutathione S-transferase ; JNK, c-Jun N-terminal kinase ; MAPK, mitogen-activated protein kinase ; MBP, myelin basic protein ; MEF, mouse embryonic fibroblast ; MEK, mitogen/extracellular regulated protein kinase ; m.o.i., multiplicity of infection ; null mouse, a mouse from which a specific gene has been embryonically deleted ; Rb, retinoblastoma gene product. 1 To whom correspondence should be addressed (e-mail pdent!hsc.vcu.edu).
pression of p21 Cip-"/WAF" increased, cdk2 and cdk4 activities decreased and DNA synthesis decreased. In contrast with these findings, prolonged activation of the MAPK pathway in hepatocytes from p21 Cip-"/WAF" -null mice enhanced cdk2 and cdk4 activities and caused a large increase in DNA synthesis, despite elevated expression of p16 INK%a . Inhibition of RhoA GTPase activity in p21 Cip-"/WAF" -null cells partly blunted both the basal levels of DNA synthesis and the ability of prolonged MAPK signalling to increase DNA synthesis. Expression of anti-sense p21 Cip-"/WAF" in either wild-type or p16 INK%a -null hepatocytes decreased the ability of prolonged MAPK signalling to increase the expression of p21 Cip-"/WAF" , and permitted MAPK signalling to increase both cdk2 and cdk4 activities and DNA synthesis. These results argue that the ability of prolonged MAPK signalling to inhibit DNA synthesis in hepatocytes requires the expression of p21 Cip-"/WAF" , and that the increased expression of p16 INK%a has a smaller role in the ability of this stimulus to mediate growth arrest. Our results also suggest that RhoA function can modulate DNA synthesis in primary hepatocytes via the expression of p21 Cip-"/WAF" and p27 Kip-" .
Recently, two signalling pathways leading to increased DNA synthesis in primary hepatocytes have been shown to be the cJun N-terminal kinase (JNK) and the p38-reactivating kinase pathways [4, 6] . In contrast, signalling by the p42\44 mitogenactivated protein kinase (MAPK) pathway seemed to have a smaller role in stimulating hepatocyte DNA synthesis [4] , but was shown to have a prominent role in causing cell cycle arrest in these cells [9] . The ability of MAPK to cause cell cycle arrest in these studies was correlated with increased expression of the cyclin-dependent kinase inhibitor (CKI) proteins p21 Cip-"/WAF" and p16 INK%a , but not the CKI protein p27 Kip-" [9] . The relative abilities of p21 Cip-"/WAF" and p16 INK%a to each inhibit DNA synthesis in primary hepatocytes were not investigated.
Hepatoma cells that are incapable of increasing p21 Cip-"/WAF" expression are known to be more tumorigenic in i o than hepatoma cells that still retain the ability to express p21 Cip-"/WAF" [10] . This has been suggested to be due in part to the loss of p53 function, although several studies have reported that childhood hepatomas and early-stage adult liver cancers express functional p53 [11] [12] [13] . Indeed, a decrease in the ability of many cell types to increase p21 Cip-"/WAF" expression has also been suggested to be important in the process of transformation and differentiation [14, 15] . This might be due to a loss of transcription factor function(s), or to altered signalling via other pathways that regulate p21 Cip-"/WAF" expression, e.g. signalling via the RhoA GTPase [16] [17] [18] . In further agreement with the importance of p21 Cip-"/WAF" expression in hepatocyte cell cycle control, it was recently demonstrated that inducible overexpression of p21 Cip-"/WAF" could blunt liver regeneration after partial hepatectomy [19] [20] [21] . Together these results suggest that regulation of p21 Cip-"/WAF" expression and function might have a pivotal role both in the regulation of liver regeneration and in hepatocellular transformation. These studies were initiated to determine whether the increased expression of either p21 Cip-"/WAF" or p16 INK%a , or both CKI molecules, was required to mediate MAPK-dependent cell cycle arrest in primary mouse hepatocytes. We discovered that prolonged activation of the MAPK pathway promoted DNA synthesis in primary hepatocytes from p21 Cip-"/WAF" -null mice (from which the gene had been embryonically deleted), but not in hepatocytes from either wild-type or p16 INK%a -null mice. Inhibition of signalling from the RhoA GTPase, via the expression of dominant-negative RhoA (N19), increased the basal expression of p21 Cip-"/WAF" , caused a small increase in basal p27 Kip-" expression and caused a large decrease in DNA synthesis. Furthermore the expression of RhoA (N19) increased the ability of prolonged MAPK signalling to inhibit DNA synthesis in wild-type hepatocytes. The expression of RhoA (N19) in p21 Cip-"/WAF" -null hepatocytes had a decreased ability to lower basal DNA synthesis compared with wild-type cells, and partly blunted the ability of prolonged MAPK signalling to increase growth.
Our results argue that p21 Cip-"/WAF" has a prominent role in the ability of prolonged MAPK signalling to inhibit DNA synthesis, whereas p16 INK%a seems to be marginally involved. Our results also argue that signalling from the RhoA GTPase inhibits the expression of p21 Cip-"/WAF" and that decreased RhoA signalling functions to inhibit DNA synthesis via increased p21 Cip-"/WAF" expression and by other mechanism(s) such as increased p27 Kip-" expression.
MATERIALS AND METHODS

Materials
Male C57BL\6J wild-type, p21 Cip-"/WAF" -null and p16 INK%a -null mice (30 g) had access to food and water ad libitum. Anti-p42 MAP kinase (sc-154AC), anti-(CCAATT enhancer-binding protein β) (C\EBPβ ; sc-150), anti-C\EBPα (sc-61), anti-(human p53) (sc-126), anti-(rodent p53) (sc-100), anti-(cyclin-dependent kinase 2) (anti-cdk2 ; sc-163AC), anti-cdk4 (sc-601AC), anti-p16 INK%a (sc-1207), anti-p27 Kip-" (sc-528), anti-p21 Cip-" (sc-397-G and sc-817), anti-(cyclin A) (sc-596), anti-(cyclin D) (sc-753) and anti-(cyclin E) (sc-481) were from Santa Cruz Biotechnology (Santa Cruz Biotechnologies, CA, U.S.A.). [γ-$#P]ATP and [$H]thymidine were from NEN. Western immunoblotting was performed with the enhanced chemiluminescence system (Amersham). Protein preparations of other reagents were as in [4, 6, 9] . Plasmids containing anti-sense C\EBPα and anti-sense C\EBPβ were generated from sense plasmids described in [7, 21] . Dominant-negative p53(R175H) was a gift from Dr. B. Vogelstein [22] . Dominant-negative mitogen\extracellular regulated protein kinase 1 (MEK1) S218A was a gift from Dr. C. Marshall [9] . The specific MEK1\2 activation inhibitor PD98059 [23] was a gift from Parke Davis\ Warner Lambert.
Recombinant adenoviral vectors ; generation and infection in vitro
Studies were performed with two adenoviral technologies. Replication-defective adenovirus was conjugated to poly-(-lysine) as described in [6, 24] . The DNA-conjugated virus was added to hepatocytes at a multiplicity of infection (m.o.i.) of 500 and the cells were incubated for 4 h at 37 mC. The cells were washed with medium to remove virus. Cells expressed transduced gene products 10-24 h after infection. Using a plasmid to express β-galactosidase under control of the CMV-promoter, we determined that 1 µg of plasmid conjugated to virus particles and infected into mouse hepatocytes before plating at an m.o.i. of 500 gave 100 % infection as judged by blue coloration after incubation with 5-bromo-4-chloroindol-3-yl-β--galactopyranoside 24 h after infection. Secondly, we have generated recombinant adenoviruses [9, 25] . To assess the effectiveness of recombinant adenoviral infection, we generated a recombinant adenovirus containing the gene for β-galactosidase. Primary mouse hepatocytes were infected with this virus after isolation in itro (m.o.i. 500), and incubated at 37 mC for a further 24 h ; cells were fixed and incubated with 5-bromo-4-chloroindol-3-yl-β--galactopyranoside. To assess infection, we performed immunoblots 10-24 h after infection [6, 9] . An m.o.i. of 100 gave 100 % infection after 24 h.
Preparation of mouse hepatocytes
Mice were anaesthetized by intraperitoneal injection of sodium pentobarbital (50 mg\kg), and the lower thorax and abdomen were shaved to remove fur. A small (3 cm) vertical mid-line incision was made in the abdominal wall from just below the costal margin\xiphoid process. Hepatocytes were prepared by cannulation of the portal vein, collagenase perfusion of the liver, and washing in Dulbecco's modified Eagle's medium (DMEM) containing 5 % (v\v) fetal calf serum as described [4] . Before plating, cells were resuspended in DMEM alone [4] .
Primary culturing, hormonal treatment and assay for DNA synthesis in cultures of hepatocytes
Mouse hepatocytes were cultured on rat-tail collagen (Vitrogen)-coated plastic dishes (12 mmi20 mm, 2i10& cells) in 1 ml of DMEM in air\CO # (19 : 1) supplemented with 50 nM insulin\1 nM dexamethasone\1 nM thyroxine, and left to adhere to the dish. In ' ∆Raf-1 : ER ' adenoviral infection experiments medium did not contain Phenol Red indicator. At this time, cells were infected with various adenoviruses, depending on the experiment. For cells undergoing acute assay, treatments occurred 90 min after plating. For adenovirally infected cells, 4 h after infection, medium was replaced and hepatocytes were cultured in the same supplemented DMEM for 24 h. Hormonal treatments and\or protein kinase inhibitors were added 24 h after the medium change (protein kinase inhibitors were added 30 min before further treatment) ; 24 h after infection, hepatocytes were treated for 6 h with 50 nM 4-hydroxytamoxifen. Hepatocytes were cultured for a further 18 h without drug. The activity of p42 MAP kinase was determined before 4-hydroxytamoxifen addition, 20 min and 6 h after the start of treatment, and then a further 18 h after the removal of the 4-hydroxytamoxifen. At 20 s before termination, medium was aspirated ; this was followed by immediate homogenization. Cells were homogenized in 1 ml of ice-cold homogenization buffer A [25 mM Hepes (pH 7.4 at 4 mC)\5 mM EDTA\5 mM EGTA\5 mM benzamidine\1 mM PMSF\40 µg\ml pepstatin A\1 µM microcystin-LR\0.5 mM sodium vanadate\0.5 mM sodium pyrophosphate\0.05 % sodium deoxycholate\1 % (v\v) Triton X-100\0.1 % (v\v) 2-mercaptoethanol], with trituration by using a P1000 pipette to lyse the cells. Homogenates were stored on ice before clarification by centrifugation (4 mC) ; clarified aliquots were subjected to immunoprecipitation. For DNA synthesis assays, hepatocytes were isolated from wild-type, p16 INK%a -null, and p21 Cip-"/WAF" -null mice and infected with an oestrogen receptor-Raf-1 fusion protein (∆Raf : ER) or with a kinaseinactive mutant [∆Raf : ER(301)]. At 24 h after infection, hepatocytes were treated for 6 h with 50 nM 4-hydroxytamoxifen. Hepatocytes were cultured in the presence of 10 µCi of [$H]thymidine for a further 24 h, after which cells were lysed with 0.5 M NaOH and DNA was precipitated with 12.5 % (w\v) trichloroacetic acid (final concn.). Acid-precipitable material was transferred to glass fibre filters and washed with 5 % (w\v) trichloroacetic acid, then [$H]thymidine incorporation into DNA was quantified by liquid-scintillation spectrometry [4] .
Immunoprecipitations from homogenates
Protein A-agarose slurry (50 µl; 25 µl bead volume) was washed twice with 1 ml of PBS containing 0.1 % (v\v) Tween 20, and resuspended in 0.1 ml of the same buffer. Antibodies (2 µg, 20 µl) or serum (20 µl) were added to each tube and incubated for 3 h at 4 mC. Clarified hepatocyte homogenates (1.0 ml, 1 mg of total protein) were mixed with Protein A-agarose-conjugated antibody in duplicate with gentle agitation for 2.5 h at 4 mC. Protein A-agarose was recovered by centrifugation ; the supernatant was then discarded and washed (10 min) sequentially with 0.5 ml of buffer A (twice), PBS and buffer B [25 mM Hepes (pH 7.4)\ 15 mM MgCl
Assay of p42
MAP kinase activity
Immunoprecipitates were suspended in a final volume of 50 µl of buffer B containing 0.2 mM [γ-$#P]ATP (2000 c.p.m.\pmol), 1 µM microcystin-LR and 0.5 mg\ml myelin basic protein (MBP), which initiated reactions ; the mixture was incubated at 37 mC. After 20 min, 40 µl of the reaction mixture was spotted on 2 cm circles of P81 phosphocellulose paper (Whatman, Maidstone, Kent, U.K.) and immediately placed into 180 mM phosphoric acid. Papers were washed four times (10 min each) with phosphoric acid and once with acetone, and $#P incorporation into MBP was quantified by liquid-scintillation spectroscopy. Preimmune controls were performed to ensure that MBP phosphorylation was dependent on specific immunoprecipitation of p42 MAP kinase [4] .
Assay of cdk2 and cdk4 activities
cdk2 and cdk4 activities were measured in immunoprecipitates of whole-cell lysates 24 h after treatment of cells with 4-hydroxytamoxifen. Approx. 100 µg of cellular protein from whole-cell homogenates (prepared as described above) was incubated with agarose-conjugated anti-cdk2 IgG or anti-cdk4 IgG on ice in 200 µl for at least 2 h each. Immunocomplexes were washed three times with 30 mM Hepes (pH 7.4)\15 mM MgCl # \80 mM β-glycerophosphate\2.6 mM EGTA\1 µg\ml chymostatin\ 1 µg\ml leupeptin\1 µg\ml antipain\1 µg\ml pepstatin\1 µg\ml soybean trypsin inhibitor\0.5 % (v\v) Nonidet P40] and then resuspended in 35 µl of the same buffer without Nonidet P40. Protein kinase assays were conducted by assaying 10 µl of immunoprecipitated samples in triplicate in a total of 25 µl containing final concentrations of 30 mM Hepes (pH 7.4)\ 0.1 mM dithiothreitol\25 mM MgCl # \30 mM β-glycerophosphate\0.5 µM protein kinase A inhibitor peptide (TTTAD-FIAGRRNAIHD)\0.1 mM [γ-$#P]ATP (10 000 c.p.m.\pmol)\ 2 mM EGTA containing 0.5 mg\ml histone H1 (for cdk2 assays) or 2 µg of glutathione S-transferase (GST)-retinoblastoma (Rb) protein (residues 379-928) (for cdk4 assays). For cdk2 assays, after 15 min of incubation at 37 mC, assays were stopped by pipetting 20 µl of the reaction mixture on P81 papers as in the MAPK assay described above, and $#P incorporation into histone H1 was quantified by liquid-scintillation spectroscopy [9] . For cdk4 assays, reactions were terminated by the addition of SDS\PAGE sample buffer followed by SDS\PAGE [10 % (w\v) gel]. GST-Rb protein was revealed by staining with Coomassie Blue, and $#P incorporation into excised GST-Rb bands was determined by liquid-scintillation spectroscopy.
Data analysis
Comparison of the effects of various treatments was done with one-way analysis of variance and a two-tailed t-test. Differences with P 0.05 were considered statistically significant. Experiments shown are the meanspS.E.M. for multiple individual points from multiple separate experiments (with hepatocytes from different animals).
RESULTS
Prolonged activation of the MAPK cascade increases p21
Cip-1/WAF1
and p16
INK4a expression in primary mouse hepatocytes
Hepatocytes were isolated from wild-type, p16 INK%a -null and p21 Cip-"/WAF" -null mice and infected with a construct to express an inducible ∆Raf : ER, or with ∆Raf : ER(301). Cells were treated with 4-hydroxytamoxifen as described in the Materials and methods section and the activity of p42 MAP kinase was determined. Treatment of wild-type hepatocytes expressing ∆Raf : ER with 4-hydroxytamoxifen increased MAPK activity approx. 6-fold after 6 h, which fell 18 h after the removal of drug to approx. 5-fold above basal levels ( Table 1) . MAPK activation was blocked by incubation with the specific inhibitor of MEK1\2, PD98059 (50 µM), or by coexpression of dominant-negative MEK1 (results not shown) (in agreement with [9] ). This prolonged MAPK activation caused an increase in p16 INK%a and p21 Cip-"/WAF" protein expression ( Figure 1A ). No increase in MAPK activity or in p16 INK%a and p21 Cip-"/WAF" protein expression was observed in 4-hydroxytamoxifen-treated hepatocytes infected with ∆Raf : ER(301) (results not shown, and Figure 1A ) [9] .
Although MAPK-induced p21 Cip-"/WAF" expression was blocked by incubation with 50 µM PD98059 and by the expression of anti-sense C\EBPα or dominant-negative MEK1, it was not decreased by the expression of either dominant-negative p53 (R175H) or anti-sense C\EBPβ ( Figure 1A , and results not shown) (in agreement with [9, 18] ). The expression of either antisense C\EBPα, dominant-negative p53 (R175H) or anti-sense C\EBPβ did not alter the ability of ∆Raf : ER to activate the MAPK pathway. The infection of constructs to express either anti-sense C\EBPα or anti-sense C\EBPβ decreased p42 C\EBPα 
ER with 4-hydroxytamoxifen for 6 h causes activation of MAPK, which is maintained for 18 h after the removal of 4-hydroxytamoxifen
Hepatocytes were infected with either ∆Raf : ER poly-(L-lysine) adenovirus or ∆Raf : ER(301) (results not shown) poly-(L-lysine) adenovirus (each at 500 m.o.i.), followed by culturing as described in the Materials and methods section. As indicated, and in addition to ∆Raf : ER infection, cells were also infected with null recombinant adenovirus, a recombinant adenovirus expressing p21
Cip-1 anti-sense mRNA or a recombinant adenovirus expressing p21
Cip-1 sense (each at 100 m.o.i.). After 24 h to allow protein/mRNA expression, hepatocytes were treated with either vehicle control or 50 nM 4-hydroxytamoxifen for 6 h, followed by washing with warm medium and further culturing for an additional 18 h in medium without 4-hydroxytamoxifen (total time in culture 48 h). Cells were assayed for MAPK activity before the addition of 4-hydroxytamoxifen (0 min) and at 20 min, 360 min and 1440 min after the addition of 4- Cip-1 -null hepatocytes plus p21 Cip-1 sense. Hepatocytes were infected with either ∆Raf : ER(301) or ∆Raf : ER poly-(L-lysine) adenoviruses (all at 500 m.o.i. each), followed by culturing as described in the Materials and Methods section. In some experiments and in addition to ∆Raf : ER infection, cells were also infected with either a null recombinant adenovirus, a p21
Cip-1 antisense mRNA recombinant adenovirus, or a p21
Cip-1 sense recombinant adenovirus (at 100 m.o.i. each). In (A), in addition to ∆Raf : ER infection, some cells were also infected with either anti-sense C/EBPβ poly-(L-lysine) adenovirus or with anti-sense C/EBPα poly-(L-lysine) adenovirus (at 500 m.o.i. each). After 24 h to allow protein expression, hepatocytes were treated with either vehicle control or with 50 nM 4-hydroxytamoxifen for 6 h, followed by washing with warm medium and further culturing for an additional 18 h in medium without 4-hydroxytamoxifen (total time in culture 48 h). Protein expression of p21
Cip-1 and Cip-1 -null hepatocytes plus p21 Cip-1 sense. Hepatocytes were infected with either ∆Raf : ER(301) poly-(L-lysine) adenovirus or ∆Raf : ER poly-(L-lysine) adenovirus (all at 500 m.o.i. each), followed by culturing as described in the Materials and Methods section. In some experiments, and in addition to ∆Raf : ER infection, cells were also infected with either null recombinant adenovirus, p21
Cip-1 anti-sense recombinant adenovirus, or p21 Cip-1 sense adenovirus (at 100 m.o.i. each). After 24 h to allow protein expression, hepatocytes were treated with either vehicle control or 50 nM 4-hydroxytamoxifen (TAM) for 6 h, followed by washing with warm medium and further culturing for an additional 18 h in medium without 4-hydroxytamoxifen. Cells were assayed for either cdk2 activity (against histone H1) or for cdk4 activity (against GST-Rb protein residues 379-928) 1440 min after the addition of 4-hydroxytamoxifen. Results are meanspS.E.M. for quadruplicate experiments from three animals expressed as the fold alteration in cdk2 or cdk4 activity. The basal activity of cdk2/cdk4 in ∆Raf : ER(301) cells without treatment with 4-hydroxytamoxifen was defined as 1.00. The basal activities were as follows : in (A), wild-type hepatocytes cdk2 8812p1500 c.p.m., cdk4 716p68 c.p.m. ; in (B), p16 In experiments identical with those above, MAPK activity also remained elevated 24 h after drug removal in p16 INK%a -null hepatocytes expressing p21 Cip-"/WAF" anti-sense mRNA (Table 1) , in wild-type hepatocytes expressing p21 Cip-"/WAF" anti-sense mRNA (Table 1 ) and in p21 Cip-"/WAF" -null hepatocytes overexpressing p21 Cip-"/WAF" protein ( Table 1 ). The expression of fulllength human p21 Cip-"/WAF" anti-sense mRNA blunted the ability of mouse hepatocytes to increase mouse p21 Cip-"/WAF" protein levels ( Figures 1D and 1E) . The constitutive expression of p21 Cip-"/WAF" in p21 Cip-"/WAF" -null cells did not alter the ability of MAPK to induce p16 INK%a ( Figure 1F) . The cross-species effectiveness of the anti-sense p21 Cip-"/WAF" probably relates to the extensive nucleic acid sequence conservation between mouse and human p21 Cip-"/WAF" genes [26] . These results demonstrate that we can elevate MAPK activity via ∆Raf : ER and that we can manipulate p21 Cip-"/WAF" and p16 INK%a CKI protein expression in primary mouse hepatocytes via both k\k-null mouse and antisense mRNA technologies.
Prolonged MAPK activation inhibits cdk2 and cdk4 activities in wild-type and p16
INK4a
-null hepatocytes but not in p21
-null hepatocytes
Experiments parallel to those described above were performed to examine the ability of prolonged MAPK signalling to alter the activities of cdk2 and cdk4 in wild-type, p16 INK%a -null and p21 Cip-"/WAF" -null hepatocytes 24 h after treatment with 4-hydroxytamoxifen ( Figure 2 ). Prolonged activation of MAPK decreased cdk2\cdk4 activities in wild-type hepatocytes ( Figure  2A ) and in p16 INK%a -null hepatocytes ( Figure 2B ) but increased cdk2\cdk4 activities in p21 Cip-"/WAF" -null hepatocytes ( Figure  2C ).
The expression of anti-sense p21 Cip-"/WAF" mRNA in both p16 INK%a -null hepatocytes ( Figure 2D ) and wild-type hepatocytes ( Figure 2E ) permitted prolonged activation of the MAPK pathway to stimulate cdk2\cdk4 activities in these cells. The ability of prolonged MAPK signalling to increase cdk2\cdk4 activities in p21 Cip-"/WAF" -null hepatocytes was blocked by overexpression of p21 Cip-"/WAF" ( Figure 2F ). Prolonged MAPK activation did not significantly alter the protein expression of cdk2, cdk4, cyclin A, and cyclin E in wild-type, p16 INK%a -null or p21 Cip-"/WAF" -null hepatocytes (results not shown). However, prolonged activation of MAPK caused a 5-fold increase in the expression of cyclin D1, which was inhibited by 75p11 % (n l 3) when cells were incubated with 50 µM PD98059 (results not shown). These results demonstrate that the loss of p21 Cip-"/WAF" expression permits prolonged MAPK signalling to increase the activities of cdk2 and cdk4 above basal levels. Because the activities of cdk2 and cdk4 are important in the ability of cells to progress through G " and to enter S phase, we next examined the Figure 2 , prolonged MAPK activity decreased DNA synthesis in wild-type and p16 INK%a -null hepatocytes ( Table 2 ). The ability of prolonged MAPK signalling to inhibit DNA synthesis in p16 INK%a -null hepatocytes was statistically less than its ability to do similarly in wild-type hepatocytes (P 0.02). These results argue that expression of p16 INK%a has a modest role in the MAPK-mediated inhibition of DNA synthesis in primary hepatocytes. Also in agreement with cdk2\cdk4 activity results in Figure 2 , prolonged MAPK activity increased DNA synthesis in p21 Cip-"/WAF" -null hepatocytes (Table 2 ). These results demonstrate that the ability of prolonged MAPK signalling to inhibit DNA synthesis in primary hepatocytes requires p21 Cip-"/WAF" expression.
To confirm that p21 Cip-"/WAF" was a more important mediator of MAPK-induced DNA synthesis inhibition than p16 INK%a , we performed experiments in which wild-type and p16 INK%a -null hepatocytes were infected with the construct to express p21 Cip-"/WAF" anti-sense mRNA. Expression of p21 Cip-"/WAF" antisense mRNA in both p16 INK%a -null hepatocytes and in wild-type hepatocytes blocked the ability of prolonged MAPK activation to increase p21 Cip-"/WAF" expression (Table 1 , Figures 1D and 1E ) but permitted the ability of this stimulus to increase DNA synthesis (Table 2 ). In addition, exogenous overexpression of p21 Cip-"/WAF" protein in p21 Cip-"/WAF" -null hepatocytes blocked the ability of prolonged MAPK signalling to increase DNA synthesis (Table 2) . These results support the view that the most important molecular mechanism by which prolonged MAPK signalling inhibits DNA synthesis in primary cultures of mouse hepatocytes is via increasing protein levels of p21 Cip-"/WAF" and not those of p16 INK%a .
Inhibition of RhoA signalling increases the basal expression of p21
Cip-1/WAF1 and potentiates the ability of prolonged MAPK signalling to decrease DNA synthesis It was recently demonstrated in Swiss 3T3 cells that signalling from the Rho GTPase exerts a negative regulatory effect on the ability of v-Ha-Ras (V12) to increase p21 Cip-"/WAF" protein levels [16] . Because v-Ha-Ras (V12) can modulate the activities of many downstream pathways, e.g. the MAPK and JNK pathways, and because of our results (Tables 1 and 2 , Figures 1 and 2) , we next examined the ability of dominant-negative RhoA (N19) to alter the ability of ∆Raf : ER, via the MAPK pathway, to modulate p21 Cip-"/WAF" expression and DNA synthesis in wildtype and p21 Cip-"/WAF" -null hepatocytes.
In either wild-type or p21 Cip-"/WAF" -null hepatocytes, the expression of dominant-negative RhoA (N19) did not alter the ability of ∆Raf : ER to activate the MAPK pathway (results not shown, in agreement with Table 1 ). The expression of RhoA (N19) in wild-type cells increased in the basal expression of p21 Cip-"/WAF" caused a small increase in the basal expression of p27 Kip-" and did not alter the expression of p16 INK%a ( Figure 3A) . Expression of RhoA also reduced cyclin E expression by approx. 50 % (results not shown). Expression of RhoA (N19) in Hepatocytes were infected with either ∆Raf : ER(301) poly-(L-lysine) adenovirus or ∆Raf : ER poly-(L-lysine) adenovirus (each at 500 m.o.i.), followed by culturing as described in the Materials and methods section. In some experiments and in addition to ∆Raf : ER infection, cells were also infected with null recombinant adenovirus, p21
Cip-1 anti-sense recombinant adenovirus (p21 Cip-1 as) or p21
Cip-1 sense adenovirus (each at 100 m.o.i.). After 24 h to allow protein expression, hepatocytes were treated with either vehicle control or 50 nM 4-hydroxytamoxifen (TAM) for 6 h, followed by washing with warm medium and further culturing for 18 h in medium without 4-hydroxytamoxifen (total time in primary culture 48 h). In some experiments, before 4-hydroxytamoxifen addition, cells were treated with 50 µM PD98059. Hepatocytes under all conditions were continually incubated with 10 µCi 
, p21
Cip-1 and p27 Kip-1 in wild-type and p21 Cip-1 -null hepatocytes ; (B) ability of ∆Raf :ER to alter p21 Cip-1 expression in the presence or absence of RhoA (N19) co-expression in wild-type and p21
Cip-1 -null hepatocytes. Hepatocytes were infected with either ∆Raf : ER(301) or ∆Raf : ER poly-(L-lysine) adenoviruses (all at 500 m.o.i. each), followed by culturing as described in the Materials and Methods section. In addition to ∆Raf : ER infection, cells were also infected where indicated with either null poly-(L-lysine) adenovirus or RhoA (N19) poly-(L-lysine) adenovirus (at 500 m.o.i. each). After 24 h to allow protein expression, hepatocytes were treated with either vehicle control or with 50 nM 4-hydroxytamoxifen for 6 h, followed by washing with warm medium and further culturing for an additional 18 h in medium without 4-hydroxytamoxifen (total time in culture 48 h). Protein expression of p16
INK4a
, p21
Cip-1 and p27
Kip 
Table 3 Expression of dominant-negative RhoA decreases basal DNA synthesis and potentiates the ability of prolonged MAPK signalling to inhibit DNA synthesis in wild-type hepatocytes
Hepatocytes were infected with either ∆Raf : ER(301) poly-(L-lysine) adenovirus or ∆Raf : ER poly-(L-lysine) adenovirus (each at 500 m.o.i.), followed by culturing as described in the Materials and methods section. In addition to ∆Raf : ER infection, cells were also infected with either null poly-(L-lysine) adenovirus or dominant-negative RhoA (N19) poly-(L-lysine) adenovirus (each at 500 m.o.i.). After 24 h to allow protein expression, hepatocytes were treated with either vehicle control or 50 nM 4-hydroxytamoxifen (TAM) for 6 h, followed by washing with warm medium and further culturing for 18h in medium without 4-hydroxytamoxifen (total time in primary culture 48 h). In some experiments, before the addition of 4- p21 Cip-"/WAF" -null cells also caused a small increase in the basal levels of p27 Kip-" ( Figure 3A ). Inhibition of RhoA GTPase function further increased the ability of MAPK signalling to elevate p21 Cip-"/WAF" expression in wild-type cells ( Figure 3B ). Increased MAPK signalling did not alter expression levels of p27 Kip-" in either wild-type or p21 Cip-"/WAF" -null cells (results not shown) (in agreement with data [9] ). These results argue that RhoA function negatively regulates the protein expression of p21 Cip-"/WAF" , and to a smaller extent p27 Kip-" , in primary hepatocytes (in agreement with [16, 17, 27] ). Because the inhibition of RhoA function increased the expression of CKI proteins, we next investigated whether this impinged on the ability of hepatocytes to synthesize DNA. The expression of RhoA (N19) significantly decreased basal DNA synthesis in both wild-type and p21 Cip-"/WAF" -null hepatocytes, although the ability of RhoA (N19) to inhibit DNA synthesis was partly decreased in p21 Cip-"/WAF" -null cells compared with wild-type cells (Table 3 ; P 0.05). The expression of RhoA (N19) increased the ability of MAPK signalling to block DNA synthesis in wild-type cells and decreased by 25 % the ability of MAPK signalling to increase DNA synthesis in p21 Cip-"/WAF" -null cells (Table 3 ; 3.2-fold compared with 2.4-fold ; P 0.05). Thus inhibition of RhoA function increases the expression of the CKI molecules p21 Cip-"/WAF" and p27 Kip-" , which can each function to inhibit hepatocyte DNA synthesis [16, 27] . Our results also demonstrate that combined inhibition of the MAPK and RhoA pathways decreases basal DNA synthesis by approx. 70 % in wild-type and p21 Cip-"/WAF" -null cells, suggesting that activations of stress pathways and the MAPK pathway are critical in the mitogenic responses of primary hepatocytes in itro [4, 6, 9] .
DISCUSSION
Expression of the CKI p21 Cip-"/WAF" has been proposed to have an important role in the control of the cell cycle in many cell types, including hepatocytes in i o and in itro [9, 10, [13] [14] [15] [16] [17] [18] [19] [20] [21] . We recently demonstrated that prolonged activation of the MAPK pathway increases the expression of two CKI proteins, p16 INK%a and p21 Cip-"/WAF" , in primary rat hepatocytes and causes a decrease in DNA synthesis [9] . These studies were initiated to determine whether the increased expression of p21 Cip-"/WAF" or p16 INK%a , or both CKI proteins, was responsible for the observed decrease in DNA synthesis in primary hepatocytes caused by prolonged MAPK activation.
We demonstrated that prolonged activation of the MAPK pathway inhibited cdk2\cdk4 activities and decreased DNA synthesis in both wild-type and p16 INK%a -null mouse hepatocytes. The ability of MAPK to inhibit DNA synthesis was statistically less in p16 INK%a -null hepatocytes than in wild-type hepatocytes. However, in p21 Cip-"/WAF" -null hepatocytes, prolonged activation of the MAPK pathway potently increased cdk2\cdk4 activities and stimulated DNA synthesis. Anti-sense neutralization of p21 Cip-"/WAF" protein expression in either wild-type or p16 INK%a -null hepatocytes permitted prolonged activation of the MAPK pathway to stimulate cdk2\cdk4 activities and increase DNA synthesis. These results indicate that in response to prolonged MAPK activation, increased expression of p21 Cip-"/WAF" has a more important role than increased expression of p16 INK%a in blunting hepatocyte DNA synthesis.
It was recently demonstrated that signalling from the Rho GTPase negatively regulated the v-Ha-Ras (V12)-induced expression of p21 Cip-"/WAF" in fibroblasts [16] . We have confirmed and extended these observations in epithelial cells by using a specific activator of the MAPK pathway, ∆Raf :ER. Our results also demonstrate that positive signalling from the RhoA pathway negatively regulates the expression of p27 Kip-" , in agreement with results in [17, 27] . This suggests that co-ordinated signalling via the MAPK and RhoA pathways regulates expression of the CKIs p16 INK%a , p21 Cip-"/WAF" and p27 Kip-" . Further studies will be needed to understand the signalling processes downstream of MAPK and RhoA by which they regulate hepatocyte DNA synthesis via CKI expression.
Most of our studies focused on the interactions between MAPK signalling and the expression of p21 Cip-"/WAF" and p16 INK%a . It was recently shown in passaged mouse embryonic fibroblasts (MEFs) that prolonged activation of the MAPK pathway inhibited DNA synthesis in wild-type fibroblasts but stimulated DNA synthesis in p21 Cip-"/WAF" k\k cells [28] [29] [30] [31] . Furthermore, and in agreement with an inability of dominantnegative p53(R175H) to block MAPK-induced expression of p21 Cip-"/WAF" in primary hepatocytes, these studies also demonstrated that MAPK signalling induced p21 Cip-"/WAF" expression in p53 k\k MEFs [18, 30] . The ability of prolonged activation of the MAPK pathway to increase p16 INK%a expression in these studies was not determined.
Other groups have examined the ability of oncogenic v-HaRas to promote DNA synthesis and colony formation in p16 INK%a -null MEFs [32] [33] [34] . These studies found that expression of oncogenic v-Ha-Ras (V12), which can cause constitutive activation of the MAPK pathway, increased DNA synthesis and colony formation ability in p16 INK%a -null MEFs but not in wildtype cells. The ability of oncogenic v-Ha-Ras (V12) to increase p21 Cip-"/WAF" in these studies was not determined. Our results in primary hepatocytes suggest a greater role for p21 Cip-"/WAF" than p16 INK%a in mediating growth arrest, which correlates more closely with results in [28] [29] [30] [31] than with those in [32] [33] [34] . Differences between our results and those in [28] [29] [30] [31] [32] [33] [34] might depend on the use of epithelial rather than fibroblast cells, the use of unpassaged primary adult cells rather than passaged embryonic cells, or the presence of serum in the culture medium.
That p21 Cip-"/WAF" -null primary hepatocytes do not arrest their growth in response to prolonged MAPK signalling was unexpected because they possess a functional Rb protein and can express p16 INK%a ( Figure 1C ). Increased expression of p16 INK%a would be expected to inhibit cdk4 activity, blocking both Rb phosphorylation and its inactivation. Our results suggest that p21 Cip-"/WAF" has a more prominent role in regulating cdk4 activity and cell cycle progression in hepatocytes, which has been suggested by others [19, 20] . Another possibility is that the amount of p16 INK%a synthesized by prolonged MAPK signalling in primary hepatocytes is insufficient to inhibit cdk4 activity fully in i o and cause arrest in the absence of p21 Cip-"/WAF" expression. This possibility might be true because prolonged MAPK signalling was statistically less efficacious in blunting DNA synthesis in p16 INK%a -null hepatocytes in comparison with wild-type cells, which suggests that increased p16 INK%a expression has a partial effect on the regulation of DNA synthesis in primary hepatocytes (Table 2) .
Results from several laboratories have suggested that MAPK signalling can induce p21 Cip-"/WAF" expression by both p53-dependent and p53-independent mechanisms [28] [29] [30] [31] 35] . The ability of MAPK signalling to increase p21 Cip-"/WAF" expression in primary mouse hepatocytes was independent of p53, which was similar to our results in primary rat hepatocytes [9] . In general agreement with these results, Serfas et al. [18] demonstrated that the ability of CCl % to increase p21 Cip-"/WAF" expression in hepatocytes in i o was p53-independent. Recently an alternatively spliced gene product from the p16 INK%a gene, termed p19 ARF , was demonstrated to have an important role in enhancing p53 activity, including the ability of p53 to induce p21 Cip-"/WAF" [22, 36, 37] . In general agreement with the lack of p53-dependence in our system, primary hepatocytes from p16 INK%a -null mice, which were therefore also null for p19 ARF , were still capable of MAPK-induced expression of p21 Cip-"/WAF" ( Figure 1B) . However, in other hepatocyte-derived cell types, e.g. HepG2 hepatoma cells, the expression of p21 Cip-"/WAF" seems to be p53-dependent [38] . These results are consistent with the possibility that p53-independent mechanisms downstream of MAPK and upstream of the p21 Cip-"/WAF" protein, which are functional in primary hepatocytes, might be non-functional in hepatoma cells. It is tempting to speculate that a decreased ability to express p21 Cip-"/WAF" might represent an early event in the process of hepatocellular transformation.
Several other transcription factors besides p53 might be able to link MAPK signalling to the regulation of the p21 Cip-"/WAF" promoter and\or protein expression. In particular, members of the C\EBP family of transcription factors have been proposed to regulate p21 Cip-"/WAF" protein levels in hepatocytes and in other cell types [7, [39] [40] [41] [42] [43] . Anti-sense C\EBPβ reduced protein levels of C\EBPβ by approx. 90 % and did not block the ability of prolonged MAPK signalling to increase p21 Cip-"/WAF" protein levels ( Figure 1A ). This suggests that C\EBPβ is not an essential mediator of MAPK signalling towards p21 Cip-"/WAF" in primary hepatocytes, although it is possible that the remaining small amounts of C\EBPβ could still mediate MAPK signalling. This seems unlikely on the basis of results presented elsewhere [7, 42] . Recent studies have suggested that the ability of C\EBPβ to regulate p21 Cip-"/WAF" expression is dependent on the function of the cAMP-dependent protein kinase [7, 42] . We have demonstrated that an elevation of cAMP levels inhibited both DNA synthesis and MAPK signalling in primary rat hepatocytes but that these two events were not causally related [4] . These findings suggest that hepatocytes might possess both cAMP-dependent and MAPK-dependent mechanisms to cause growth arrest by increasing the expression of CKI molecules.
Other investigators have suggested that the CCAAT\enhancer binding protein family member, C\EBPα, might also have a role in regulating the promoter and protein levels of p21 Cip-"/WAF" in primary hepatocytes and in hepatoma cells [18, [39] [40] [41] 43] . For example, Serfas et al. [18] demonstrated via immunohistochemistry that p21 Cip-"/WAF" expression and nuclear C\EBPα protein expression were co-localized in hepatocytes in i o. In agreement with this view, we found that anti-sense C\EBPα blunted the ability of prolonged MAPK signalling to increase p21 Cip-"/WAF" protein expression. Thus results from our own and several other laboratories suggest that C\EBP family members might have a key role in mediating MAPK signalling towards the p21 Cip-"/WAF" protein levels in hepatocytes.
Further studies, outside the scope of this paper, will be required to determine fully the molecular mechanism(s) downstream of MAPK signalling by which it regulates p21 Cip-"/WAF" promoter function and protein levels in primary cultures of mouse hepatocytes.
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